v3.25.1
Investment in Pala Diagnostics (Details Narrative) - USD ($)
1 Months Ended
Aug. 31, 2021
Oct. 31, 2021
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2021
Vivera [Member]          
[custom:LitigationReceivable-0]         $ 2,104,509
Dalrada Health [Member] | JV Pala Diagnostics Partnership Agreement [Member]          
Payments to acquire non-controlling interest $ 500,000        
Dalrada Health [Member] | JV Pala Diagnostics Partnership Agreement [Member] | Vivera Pharmaceuticals [Member]          
Stock issued for acquisition   250,000      
Fair value of goodwill       $ 58,560  
Goodwill written down     $ 0    
Vivera Pharmaceuticals [Member] | JV Pala Diagnostics Partnership Agreement [Member]          
Payments to acquire non-controlling interest $ 111,185        
JV Pala Diagnostics [Member]          
Ownership interest 51.00%